|
|
Article: Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.(AMERICAN JOURNAL OF CLINICAL DERMATOLOGY)(Reprint)(Brief article)
- Article from:
- Baylor University Medical Center Proceedings
- Article date:
- January 1, 2007
- Author:
CopyrightCOPYRIGHT 2007 The Baylor University Medical Center. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Am J Clin Dermatol 2006;7(4):213-222. Reprinted with permission from Wolters Kluwer.
Atopic dermatitis is a chronic, relapsing inflammatory skin disease that frequently affects infants and children. The worldwide prevalence of atopic dermatitis is estimated to be 5-20% of the pediatric population. Studies have shown that atopic dermatitis is associated with considerable economic costs and decreased quality of life. There is no proven curative therapy at present for atopic dermatitis; first-line therapy has generally consisted of dry skin care, avoidance of triggers, application of topical corticosteroids, and administration of histamine [H.sub.1] receptor ...